or Try an Advanced Search...

    Glucose Meter Stocks List

    Symbol Grade Name % Change
    SNY B Sanofi 0.66
    TNDM D Tandem Diabetes Care, Inc. 1.71
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Medical Devices
    Related Stock Lists: Glucose Insulin Animal Health Cac 40 Cancer Caregiver Chronic Kidney Disease Clopidogrel Colorectal Cancer Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Diabetes Diabetes Care Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dialysis Endocrine System Endocrinology

    Related ETFs - A few ETFs which own one or more of the above listed Glucose Meter stocks.

    Symbol Grade Name Weight
    PPH B Market Vectors Pharmaceutical ETF 4.47
    EDOC F Global X Telemedicine & Digital Health ETF 4.12
    VIRS B Pacer BioThreat Strategy ETF 3.87
    MEDI D Harbor Health Care ETF 3.05
    PID C PowerShares Intl Dividend Achievers 2.92
    View all Glucose Meter ETFs...
    Compare ETFs
    Compare EDOC to MEDI Compare PPH to EDOC Compare VIRS to PID

        Glucose Meter Stocks Recent News

        Date Stock Title
        Jul 3 SNY Bain, Cinven Weighing Joint Bid for $20 Billion Sanofi Unit
        Jul 3 SNY Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
        Jul 3 SNY Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
        Jul 3 SNY Sanofi, Regeneron win EU label expansion for Dupixent in COPD
        Jul 3 SNY EMA approves Sanofi’s Dupixent for COPD treatment in adults
        Jul 3 SNY Update: Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
        Jul 3 SNY Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
        Jul 2 SNY Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
        Jul 1 TNDM Tandem Diabetes (TNDM) Posts Positive Data for Tandem Mobi
        Jul 1 SNY Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
        Jul 1 SNY Bird Flu Shot Hopes Dim as Tracing Woes Undercut Covid Lessons
        Jul 1 SNY Jim Cramer Says You Should Not Buy Novavax Inc (NASDAQ:NVAX)
        Jul 1 SNY Sanofi reports findings from Phase II relapsing MS treatment trial
        Jul 1 SNY Sanofi eyes German insulin investment of up to $1.6 billion, source says
        Jun 29 SNY Where Will Novavax Be in 1 Year?
        Jun 28 SNY PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar
        Jun 28 SNY 3 Top Euronext Paris Dividend Stocks With Yields From 4% To 5.1%
        Jun 27 SNY Vigil Neuroscience jumps 34% as Sanofi invests $40M
        Jun 27 SNY Formation Bio secures $372m funds for AI-driven drug platform
        Jun 27 SNY Sanofi reports positive data from Phase III EoE treatment trial
        Related Industries: Drug Manufacturers - Major Medical Devices
        Related Stock Lists: Glucose Insulin Animal Health Cac 40 Cancer Caregiver Chronic Kidney Disease Clopidogrel Colorectal Cancer Consumer Health Care Consumer Health Care Products Deep Vein Thrombosis Diabetes Diabetes Care Diabetes Management Diabetes Mellitus Diabetes Mellitus Type 1 Dialysis Endocrine System Endocrinology
        Glucose Meter

        A glucose meter is a medical device for measuring the amount of glucose in the blood. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking the skin with a lancet, is placed on a disposable test strip that the meter reads and uses to calculate the blood glucose level. The meter then displays the level in mg/dl or mmol/l.

        Browse All Tags